5. Squamous cell carcinoma
• Squamous cell carcinoma remains the most
common sinonasal malignancy
• The majority probably arise in the maxillary sinus
• Rarely the nasal septum or columella are the
primary site.
• These tumours have a particularly poor
prognosis due to the possibility of bilateral
metastatic spread to cervical nodes.
6. ADENOCARCINOMA
• Aout 30 per cent of patients with this condition
are woodworkers.
• These tumours usually arise in the middle meatus
and spread into the ethmoid
• Adenocarcinoma is generally rather radioresistant
but combined therapy is usually offered.
• Many patients require a craniofacial but in
selected cases have been treated successfully by
an endoscopic resection.
7. Adenoid cystic carcinoma
• Propensity to spread along perineural
lymphatics which compromises attempts at
excision.
• known to produce blood-borne metastases,
classically to the lung while lymphatic spread
is rare.
• Treatment is generally combined surgery and
radiotherapy
8. OLFACTORY NEUROBLASTOMA (OR)
ESTHESIONEUROBLASTOMA
• classically arises from olfactory epithelium in the upper nasal
vault
• The presence of a mass in the upper nasal cavity with
associated skull base erosion is typical.
• bimodal peak in the second/third and sixth/seventh decades.
• Cervical metastases have been described in up to 23%.
• These are routinely resected in craniofacial approaches
• Endoscopic resection is being increasingly offered for this
tumour particularly when it arises from the middle and
superior turbinates.
• should always be combined with radiotherapy.
9. Ohngren's Line
· Line running from
medial canthus to
angle of mandible
· Prognosis of
suprastructure
tumors worse (This
was before advent of
craniofacial
resection)
12. Natural history & spread – contd…
Sphenoid sinus ca Frontal sinus ca
13. Lymphatic Drainage
• Usually sparse-10% incidence of cervical LNE
• If tumor extension into skin of face, nasal
cavity, NPX -> ↑ed incidence of LN->Assocated
with poor prognosis
• First echelon: submandibular nodes
• Second echelon: subdigastric nodes - same
side
• Contralateral mets. extremely rare
14. Clinical features
Maxillary sinus ca
• Facial swelling, pain, paresthesia of cheek
• Epistaxis, nasal discharge, obstruction
• Ill fitting dentures, alveolar/palatal mass
• Proptosis, diplopia, impaired vision, orbital pain
Ethmoid sinus ca
• Headache
• Referred pain to nasal, retrobulbar region
• SC mass at inner canthus, nasal
obstruction,discharge, diplopia & proptosis
15. Work up
• H & P
• Routine blood examination
• CXR- Adenocystic ca
• CT/MRI
• Dental evaluation
• Baseline ophthalmologic examn
• Baseline speech & swallowing assessment
• Fiberoptic endoscopic examination & Bx
16. Computed Tomography
• Bone erosion
– orbit, cribiform plate
– fovea, post max sinus wall
– sphenoid, post wall of
frontal sinus
• 85% accuracy
• ? Tumor vs. inflammation vs.
secretions
• Limitation-periorbital
involvement
• CT Chest for Adenocystic ca
19. AJCC- Nasal cavity & Ethmoid Sinus
Tx - Primary tm cannot be assessed
To - no evidence of primary tm
Tis - carcinoma in situ
T1 - Tm restricted to any one subsite with or without bony
invasion
T2 - invading two subsite in a single region or extending to
involve an adjacent region within the nasoethmoidal complex
T3 - invade medial wall/ floor of orbit, maxillary sinus,palate/
cribiform plate
T4a - invade ant orbital contents, skin of nose /cheek, ant cranial
fossa, pterygoid plates,sphenoid/ frontal sinus
T4b - orbital apex, dura, brain,mid cranial fossa, cr nerves,
nasopharynx/ clivus
20. Staging – contd…
Nx - regional nodal status cannot be assessed,
No - No regional lymph node metastasis
N1 - single I/L clinically +ve lymph node ≤ 3cm
N2 - metastasis in ipsilateral, bilateral, contralateral node
N2a - single I/L +ve LN >3cm <6cm
N2b - multiple, I/L +ve LN <6cm
N2c - B/L or C/L LN <6cm
N3 - any LN > 6cm
Mx - distant metastasis cannot be assessed
Mo - No distant metastasis
M1 -distant metastasis
21. Staging – contd…
Stagewise distribution
stage I - T1N0M0
stage II – T2N0M0
stage III – T3N0M0 OR T1-T3N1M0
stage IV :
- IVA -T4N0-1M0
any TN2 M0
- IVB any TN3M0
- IVC any T any N, M1
22. Treatment options
Maxillary sinus ca
• Surgery
• Radiotherapy
- definitive
- pre op RT
- post op RT
• Combined modality ( Sx + RT)
• Chemotherapy
- Neo adjuvant
- Concomitant
25. Surgery
Contraindications
- extension thr ant. Fossa
- involvement of both optic n.
- post. extension into sphenoid sinus
- invasion of middle cranial fossa
- extension into NPx
- inoperable neck node & distant mets
27. Craniofacial resection
• the ‘gold standard’ for tumours affecting the anterior skull
base.
CONTRAINDICATIONS
• Extensive frontal lobe and/or middle cranial fossa
involvement or bilateral orbital invasion/optic chiasm.
• Certain histologies, such as mucosal malignant melanoma
where extent of surgery does not influence outcome
• those where surgery is not appropriate, such as sinonasal
undifferentiated carcinoma, lymphoma, plasmacytoma.
• Distant metastasis.
28. INCISION
• Following bilateral temporary tarsorrhaphies,
an extended lateral rhinotomy is made on the
side of maximal tumour involvement
29. TECHNIQUE
• The soft tissues of the face are mobilized by subperiostial
elevation to expose the nasal bones, frontal processes of the
maxilla and frontal bone up to the hairline via an extended lateral
rhinotomy.
• Through the lateral rhinotomy, the upper lateral cartilage is
separated from the nasal bone to allow complete retraction of the
nasal ala.
• The orbital periosteum is elevated to expose the lacrimal fossa
and the medial orbital wall. The nasolacrimal duct is often
transacted obliquely at this point
• anterior and posterior ethmoidal arteries are divided after bipolar
coagulation.
• If the lamina has been eroded by tumour, the adjacent periorbita
should be resected for frozen section assessment
30. • A shield-shaped craniotomy is performed above the level of
the supraorbital rim to include the frontal sinus. usually
approximately 3x3x3.5 cm size.
• The frontal sinus which has been opened by this manoeuvre
is cleared of its mucosa and the posterior wall removed
combined with a wide dissection of the dura.
• Dissection around the cribriform plate and crista galli is
facilitated by the use of the operating microscope.
• This dissection continues until the cribriform plate is
exposed and continues on to the jugum of the sphenoid.
• In cases of olfactory neuroblastoma routinely the olfactory
bulb and tracts are removed in continuity.
• The anterior and posterior ethmoidal arteries are coagulated
with the bipolar diathermy although care must be exercised
as the optic nerve is approached.
33. • Osteotomies are performed around the cribriform plate
through the ethmoidal and sphenoid roofs.
• The posterior osteotomy crosses the planum sphenoidale to
include the anterior face of the sphenoid and the nasal
septum is separated by quadrilateral cuts.
• The specimen is mobilized this can be removed, haemostasis
achieved and the cavity inspected for further resection.
• fashion a large middle meatal antrostomy to prevent
subsequent infection.
• dura has small defects which can be repaired primarily but
more with fascia lata held in place with fibrin glue to which a
split-skin graft taken from the thigh is applied inferiorly.
• The frontal bone flap is replaced and secured with miniplates.
• The periosteum and subcutaneous layer is closed with
absorbable sutures and skin with clips or fine skin sutures. A
pressure dressing is applied to both the head and leg.
34. POST OP CARE
• Patients are kept in a neutral position of
approximately 15 degree for the first 2 or 3
days and then gently elevated.
• The urinary catheter is removed on the second
or third day and facial sutures after 5–7 days.
• The anticonvulsant is continued for 6 weeks
following the operation and patients must
douche the nose long term.
36. MIDFACIAL DEGLOVING
• The degloving approach affords excellent access to the middle third of the face.
• Indicated in malignant tumours affecting the nasal
cavity,maxilla,ethmoids,sphenoid, pterygopalatine and infratemporal fossae.
INCISION
• After temporary tarrsoraphies, a bilateral sublabial incision is made from
maxillary tuberosity to tuberosity down to bone
• Routine rhinoplasty intercartilaginous incisions are made extending into a
transfixion incision along the dorsal and caudal borders of the cartilaginous
septum,separating it from the medial crura of the lower lateral cartilages.
• The circumferential incisions are joined across the floor of the nose just
anterior to the pryriform aperture.
38. • The soft tissues of the midface are elevated
subperiosteally up to the infraorbital nerve on each side
to display the pyriform aperture.
• The soft tissues over the nasal bridge are elevated as far
as the root of the nose and laterally to complete the
mobilization from below so that the mid-third of the face
is completely elevated and can be lifted superiorly over
the nasal skeleton.
• nasal cavities and maxillary sinuses can be opened using
drills, hammers and osteotomes.
• maxillary and sphenopalatine arteries accessed and
ligated
41. • ethmoids, sphenoid, nasopharynx and structures
posterior and lateral to the maxillae are reached for
further resection.
• Closure of the incisions must be done with care to
avoid complications, using absorbable suture material.
• The bridge of the nose may be taped or a rhinoplasty
dressing applied for a few days.
• After pack removal patients advised to use saline
douching daily until crusting settles.
42. Lateral rhinotomy
• Indicated in any malignant tumour affecting the
nasal septum,lateral wall and extending into
ethmoid, sphenoid, maxillary sinuses and up to the
anterior skull base
INCISION
• After a temporary tarrsoraphy, the incision runs from
the level of the medial canthus, midway between the
canthus and nasal bridge in the nasomaxillary
groove, curving round the lower ala into the nasal
cavity
43. TECHNIQUE
• Through the incision, the orbital periosteum can be dissected
from the lamina and the nasolacrimal duct mobilized.The
duct can be transected obliquely adjacent to the sac.
• Anterior and posterior ethmoidal arteries ligated
• An en bloc or piecemeal removal of lateral nasal wall done
including the pyriform aperture,nasal bone,frontal process of
maxilla,anterior maxillary wall,medial orbital wall and
rim,ethmoids lamina pipyracea and lacrymal fossa depending
upon extend of tumour.
• The sphenoid sinus can be opened,frontal can be
accesed,orbital periosteum can be resected if required
44. MAXILLECTOMY
• Malignant tumors of maxilla involving all walls with/without orbital
extension.
INCISION
-Weber-Fergusson incision extends 1cm lateral to the lateral canthus
and medially 3mm below the lower eyelash.at medial canthus incision
curves inferiorly into nasomaxillay groove down to alar margin.it
continues medially to the midline where it turns at right angle dividing
the upper lip.
-incision extends round the upper alveolus in the gingivobuccal sulcus
upto maxillary tuberosity.medially incision pass to hard palate between
the central incisors as far as junction of hard and soft palate,then
crosses laterally to the poserior aspect of maxillary tuberosity
46. TECHNIQUE
• The entire soft tissue of cheek are raised subperiosteally off the
maxilla from the pyriform apperture to the zygomatic arch
including buccinator
• The orbicularis oculi left intact around the eye but the orbital
periosteum is incised at the bony rim allowing dissection of
orbital contents.infraorbital neurovascular bundle is cut at the
infra orbital foramen.
• Osteotomies are made through the zygoma beneath the
infraorbital rim,across the frontal process of maxilla,into
pyriform fossa,inferiorly through the central upper
alveolus.lateral nasal wall divided below the superior turbinate.
• Mobilization of maxilla completed by seperating the tuberosity
from the pterygoid plates.
49. • A variety of reconstructions are available.
• At its simplest,a split skin graft can be applied to the cavity
wall held in place with quilting incisions,biological glues,and
a temporary gutta percha prosthesis.
• Alternatively a free flap can be utilized, e.g. rectus abdominis,
latissimus dorsi, radial or fibula osteocutaneous flaps with
osseointegration
• Repairing lost orbital support decreases the risk of globe
malposition, diplopia and disturbance of extraocular muscle
function.
• Small defects in the floor can be left, larger ones can be
repaired using a fascia lata sling secured to the margins of
the bony defect
50. • Extensive spread of the tumour anteriorly into the
facial skin may necessitate sacrifice of this with repair
using a local pedicled or free microvascular flap.
• More frequently, extension occurs posteriorly into the
pterygoid region which adversely affects prognosis.
• Limited areas of pterygoid muscle can be removed.
• clearance of the pterygopalatine and infratemporal
fossae can be undertaken.
51. Reconstruction and Prosthetic Rehabilitation
Aim :
• - prevent contracture of the check
• -to separate oral & nasal cavities
• -to provide support for the globe .
• -An obturator should be made preoperatively
from an impression of the hard palate
53. Tumours with bad prognosis
1- Advanced maxillary cancer .
2- lesions involving pterygoid plates or
pterygopalatine fossa .
3- lesions involving brain , dura , nasopharynx ,
sphenoid .
4- lesions involving orbital contents
54. Follow up
• 3 mths after Rx
- baseline physical examn
- CT, MRI or PET CT
• 1st
3 yrs – every 4 mths
• 4th
& 5th
yr – every 6 mths
• Then - annually